NYSE:BSX

Boston Scientific Stock News

etoro logo Buy BSX
*Your capital is at risk
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Medical tech giant Boston Scientific Corporation (BSX) has announced that it has received U.S. Food and Drug Administration (FDA) approval for its
Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device.
You likely just filed your taxes and even paid some. You might wonder how some S&P 500 companies didn't pay a dime.
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medi
Exchange Traded Concepts LLC increased its holdings in Boston Scientific Co. (NYSE:BSX) by 121.0% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investo
On CNBC's "Mad Money Lightning Round," Jim Cramer said that the Beyond Meat Inc (NASDAQ: BYND) franchise is good and he likes the stock.Cramer can't recommend Scorpio Tankers Inc. (NYSE: STNG). He is
Newly released products will drive revenue growth, but will they benefit shareholders?
Medical devices giant Boston Scientific Corp. (BSX) is reportedly considering selling its specialty pharmaceutical business focused on snake venom treatments.According to people with knowledge of the
During the second quarter of 2020, UnitedHealth Group (NYSE: UNH) expanded its COVID-19 response efforts, proactively supporting patients, customers,
(Bloomberg) -- Boston Scientific Corp. is exploring a sale of its specialty pharmaceutical business focused on treatments for snake venom, which could fetch close to $1 billion, according to people wi
IFM Investors Pty Ltd lessened its position in shares of Boston Scientific Co. (NYSE:BSX) by 25.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securitie
Shares of medical device makers Becton Dickinson (NYSE: BDX), Boston Scientific (NYSE: BSX), and Medtronic (NYSE: MDT) fell by double-digit percentages in the first six months of 2020, according to
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest

Should You Buy Boston Scientific At $35?

12:00am, Wednesday, 08'th Jul 2020
Despite a 38% rise since the March 23 lows of this year, at the current price of around $35 per share we believe Boston Scientific looks attractive and it has more room for growth. Boston Scientific s
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE